Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRASH-4: Tranexamic Acid for Mild Traumatic Brain Injury in Older Adults
NCT04521881Phase 3Recruiting
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Apr 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid in traumatic brain injury (TBI), sponsored by London School of Hygiene & Tropical Medicine. Started Apr 2021; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04521881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521881.